Overview

A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures

Status:
Not yet recruiting
Trial end date:
2025-08-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the long-term safety and tolerability of Staccato alprazolam.
Phase:
Phase 3
Details
Lead Sponsor:
UCB Biopharma SRL
Treatments:
Alprazolam